Merck’s COVID-19 pill active against Omicron in lab studies
Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
Synopsis : Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed…
Summary : String Bio, a Bengaluru-based company, has developed a platform for converting methane into various solutions such as biostimulants for crops,…
Summary : Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, announced today that it was…
Synopsis : Biogen is selling its nearly 50% stake in South Korea-based Samsung Bioepis for $2.3 billion. The move will provide Biogen…
Courtesy of Alzamend Neuro On the strength of data from its Phase 1 Study of lead compound, AL001, being developed for…
Summary : Oxford Biomedica and Homology Medicines to establish Oxford Biomedica Solutions LLC, a new U.S.-based AAV Manufacturing and Innovation Business Homology…
Executive Summary The pharma also warns that an FDA complete response letter could be coming for its supplemental NDA to add atopic…
Summary : The first doses of an experimental HIV vaccine have been delivered in a phase 1 clinical trial. International AIDS Vaccine…
Summay : EAMS scientific opinion issued to Global Blood Therapeutics (UK) Ltd for Voxelotor in the treatment of hemolytic anemia in patients…